Net income
-436 thousand USD
2020-04-01 – 2021-03-31
Fundies. English
Luckwel Pharmaceuticals Inc.
EDGAR31 filing records in this dataset, filed from 2013-04-12 to 2021-09-09. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 2.04 thousand USD Source
Exact value
2044 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 147 million shares Source
Exact value
146676000 shares
Reported share-count change
2.30% · 3.3 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-198 thousand USD
2020-04-01 – 2021-03-31
Exact inputs and evidence
- Operating cash flow: -11981 USD · 2020-04-01 – 2020-06-30 Source
- Operating cash flow: -13073 USD · 2020-04-01 – 2020-09-30 Source
- Operating cash flow: -11981 USD · 2020-04-01 – 2020-06-30 Source
- Operating cash flow: -41925 USD · 2020-04-01 – 2020-12-31 Source
- Operating cash flow: -13073 USD · 2020-04-01 – 2020-09-30 Source
- Operating cash flow: -197975 USD · 2020-04-01 – 2021-03-31 Source
- Operating cash flow: -41925 USD · 2020-04-01 – 2020-12-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2021-09-09.
Financial data available through: 2021-03-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 8 of 11 periods available· newest 2021-03-31
- Operating cash flow: 8 of 11 periods available· newest 2021-03-31
- capital expenditure: No compatible figures in this window
- Total assets: 8 of 11 periods available· newest 2021-03-31
- Total liabilities: 7 of 11 periods available· newest 2021-03-31
- Current assets: 4 of 11 periods available· newest 2018-03-31
- Current liabilities: 4 of 11 periods available· newest 2018-03-31
- Cash and cash equivalents: 8 of 11 periods available· newest 2021-03-31
- long term debt: No compatible figures in this window
- Shares outstanding: 8 of 11 periods available· newest 2021-03-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 100,419Prior period
−USD 536,432
–
Current period
−USD 436,013
–
Exact inputs and evidence
-436013 − -536432 = 100419 USD
-536432 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source-436013 USD · 2020-04-01 – 2021-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 120,235Prior period
−USD 318,210
–
Current period
−USD 197,975
–
Exact inputs and evidence
-197975 − -318210 = 120235 USD
-318210 USD · 2019-04-01 – 2020-03-31
Inspect prior input Prior source-197975 USD · 2020-04-01 – 2021-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2013-03-01 – 2014-02-28 | −USD 224,603 Exact valueExact value: -224603 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 206,362 Exact valueExact value: -206362 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2014-03-01 – 2015-02-28 | −USD 264,155 Exact valueExact value: -264155 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 244,649 Exact valueExact value: -244649 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2015-03-01 – 2016-02-29 | −USD 420,728 Exact valueExact value: -420728 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 343,259 Exact valueExact value: -343259 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-04-01 – 2017-03-31 | −USD 510,708 Exact valueExact value: -510708 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 461,052 Exact valueExact value: -461052 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-04-01 – 2018-03-31 | −USD 537,088 Exact valueExact value: -537088 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 515,618 Exact valueExact value: -515618 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-04-01 – 2019-03-31 | −USD 622,526 Exact valueExact value: -622526 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 622,242 Exact valueExact value: -622242 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2019-04-01 – 2020-03-31 | −USD 536,432 Exact valueExact value: -536432 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 318,210 Exact valueExact value: -318210 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-04-01 – 2021-03-31 | −USD 436,013 Exact valueExact value: -436013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 197,975 Exact valueExact value: -197975 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
31 filings · 890 latest values · 890 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001567098, 1567098, LCOM, LWEL, edgar:1567098
Also known as LUCKYCOM INC, Luckwel Pharmaceuticals Inc., Luckycom Pharmaceuticals Inc.